New Big Data Curriculum On The Cards For EU Regulators
The European Medicines Agency is inviting feedback from organizations interested in delivering a training program to the members of the European medicines regulatory network to improve their big data analysis and assessment skills.
You may also be interested in...
A panel of regulators overseeing the implementation of several big data projects within the EU medicines network has given details of real-world evidence integration pilots to be undertaken next year by various European Medicines Agency scientific committees.
The EMA is inviting feedback on its plans to ratify, with some caveats, a new framework on how to use patient preferences as input in medical product decision-making. The framework was developed under the EU’s public-private Innovative Medicines Initiative.
The COVID-19 pandemic has given a new impetus to Sweden’s ongoing efforts to support decentralized clinical trials.